While theres anecdotal evidence touting its benefits, Eric Topol, a cardiologist and the director of Scripps Research Translational Institute, told the Post that GLP-1 microdosing is a craze that is not substantiated. Its too early for people to do this, he said, noting that its still worth researching how GLP-1s could treat age-related diseases
Thus, to clarify the interaction among these various inherited and nutritional factors and their relative involvement in cardiovascular disease, complementary prospective trials and experimental studies in transgenic animals should be performed in the future
The SURMOUNT-OSA Trial The tirzepatide data emerged from the SURMOUNT-OSA phase 3 clinical trial, which Atul Malhotra, MD, a professor and research chief of pulmonary, critical care, and sleep medicine at UC San Diego Health, presented during a session at the ADA meeting
What to do Aim for 79 hours of high-quality sleep per night
Why it matters: It is essential to remain patient and consistent during this phase, as the body adapts progressively